You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

Filters
17 September 2021
A list of tests approved for inclusion in the Australian Register of Therapeutic Goods (ARTG)
16 September 2021
Information about the TGA's safety monitoring of COVID-19 vaccines.
16 September 2021

Learn how the TGA is collaborating with international regulators to provide timely access to a COVID-19 vaccine.

16 September 2021
The TGA is undertaking a post-market review of face masks included in the ARTG. This page lists all face masks that have been cancelled from the ARTG during the review.
15 September 2021
Lawyers for the TGA have written to United Australia Party leader, Mr Craig Kelly MP, alleging it has breached copyright and demanding that it stop distributing incomplete extracts of adverse event reports relating to COVID-19 vaccines which the TGA believes could be seriously misleading.
14 September 2021
A joint statement confirming the suitability of appropriately designed immunobridging studies as an acceptable approach to authorising COVID-19 vaccines.
14 September 2021

COVID-19 vaccine batch release information is now available.

10 September 2021

Guidance for sponsors and manufacturers in preparing COVID-19 rapid antigen self-test applications

10 September 2021
General information about rapid antigen point-of-care testing in Australia
9 September 2021

Information about the TGA's safety monitoring of COVID-19 vaccines.

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us